Malignant pericardial effusion in breast cancer: Terminal event or treatable complication?

Journal of Surgical Oncology

Volumn 64, Issue 4, 1997, Pages 308-311

  Swanepoel, Etienne ^a   Apffelstaedt, Justus P ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

breast cancer; metastases; pericardial window; tamponade

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; MITOMYCIN C; MITOXANTRONE;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; DYSPNEA; FEMALE; FENESTRATION; HEALTH CARE POLICY; HUMAN; HUMAN CELL; HUMAN TISSUE; PATIENT SELECTION; PERICARDIAL EFFUSION; PRIORITY JOURNAL; RECURRENCE RISK; RISK BENEFIT ANALYSIS;

ADULT; AGED; BONE NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PERICARDIAL EFFUSION; PERICARDIAL WINDOW TECHNIQUES;

EID: 0030888397     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199704)64:4<308::AID-JSO11>3.0.CO;2-Z     Document Type: Article

References (22)

1. Theologides A: Neoplastic cardiac tamponade. Semin Oncol 1985;5:181-192.
2. Malden LT, Tattersall MHN: Malignant Effusions. Q J Med 1986; 227:221-239.
3. Beretta F, Martinelli G, Cavalli F, Marone C: Perikarderguss bei Patienten mit malignen Neoplasien. Schweiz Med Wschr 1992; 122:1517-1523.
4. Reitknecht F, Regal AM, Antkowiak JG, Takita H: Management of Cardiac Tamponade in Patients with Malignancy. J Surg Oncol 1985;30:19-22.
5. Press OW, Livingston R: Management of malignant pericardial effusion and tamponade. JAMA 1987;257:1088-1092.
6. Hawkins JW, Vacek JL: What constitutes definitive therapy of malignant pericardial effusion? Medical versus surgical treatment. Am Heart J 1989;118:428-431.
7. McKenna RJ, Ali MK, Ewer MS, Frazier OH: Pleural and pericardial effusion in cancer patients. Curr Prohl Cancer 1985;9:2-44.
8. Shepherd FA, Morgan C, Evans WK, et al.: Medical management of malignant pericardial effusion by tetracycline sclerosis. Am J Cardiol 1987;60:1161-1166.
9. Celermajer DS, Boyer MJ, Bailey BP, Tattersall MHN: Pericardiocentesis for symptomatic malignant pericardial effusion: A study of 36 patients. Med J Austr 1991;154:19-22.
10. Mills SA, Julian S, Holliday RH, et al.: Subxiphoid pericardial window for pericardial effusive disease. J Cardiovasc Surg 1989; 30:768-773.
11. Vaitkus PT, Herrmann HC, LeWinter MM: Treatment of malignant pericardial effusion. JAMA 1994;272:59-64.
12. Hagemeister FB, Buzdar AU, Luna MA, Blumenshein GR: Causes of death in breast cancer. Cancer 1980;46:162-167.
13. Buck M, Ingle JN, Giuliani ER, et al.: Pericardial effusion in women with breast cancer. Cancer 1987;60:263-269.
14. Woll PJ, Knight RK, Rubens RD: Pericardial effusion complicating breast cancer. J R Soc Med 1987;80:490-491.
15. Edoute Y, Konten A, Ben-Haim SA, et al.: Symptomatic pericardial effusion in breast cancer: The role of fluid cytology. J Surg Oncol 1990;45:265-269.
16. Bitran JD, Evans R, Brown C: The management of cardiac tamponade in patients with cancer of the hrcast. J Surg Oncol 1984; 27:42-44.
17. Reynolds PM, Byrne MJ: The management of malignant pericardial effusion in carcinoma of the breast. Aust NZJ Med 1977; 7:169-171.
18. Fontanelle LJ, Puello L, Dovley BN: Subxiphoid pericardial window. J Thorac Cardiovasc Surg 1971;62:95-97.
19. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-486.
20. Apffelstaedt J, Van Zyl JA, Muller AGS: Breast cancer complicated by pleural effusion: Patient characteristics and results of surgical management. J Surg Oncol 1995;58:173-175.
21. Callahan JA, Seward JB, Taji AJ, et al.: Pericardiocentesis assisted by two-dimensional echocardiography. J Thorac Cardiovasc Surg 1983;85:877-879.
22. Osuch JR, Khandekar JD, Fry WA: Emergency subxipoid pericardial decompression for malignant pericardial effusion. Am Surg 1985;51:298-300.